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ABSTRACT
Extracellular vesicles (EVs) are intercellular communicators with key functions in physiological and
pathological processes and have recently garnered interest because of their diagnostic and
therapeutic potential. The past decade has brought about the development and commercializa-
tion of a wide array of methods to isolate EVs from serum. Which subpopulations of EVs are
captured strongly depends on the isolation method, which in turn determines how suitable
resulting samples are for various downstream applications. To help clinicians and scientists
choose the most appropriate approach for their experiments, isolation methods need to be
comparatively characterized. Few attempts have been made to comprehensively analyse vesicu-
lar microRNAs (miRNAs) in patient biofluids for biomarker studies. To address this discrepancy, we
set out to benchmark the performance of several isolation principles for serum EVs in healthy
individuals and critically ill patients. Here, we compared five different methods of EV isolation in
combination with two RNA extraction methods regarding their suitability for biomarker discov-
ery-focused miRNA sequencing as well as biological characteristics of captured vesicles. Our
findings reveal striking method-specific differences in both the properties of isolated vesicles
and the ability of associated miRNAs to serve in biomarker research. While isolation by precipita-
tion and membrane affinity was highly suitable for miRNA-based biomarker discovery, methods
based on size-exclusion chromatography failed to separate patients from healthy volunteers.
Isolated vesicles differed in size, quantity, purity and composition, indicating that each method
captured distinctive populations of EVs as well as additional contaminants. Even though the focus
of this work was on transcriptomic profiling of EV-miRNAs, our insights also apply to additional
areas of research. We provide guidance for navigating the multitude of EV isolation methods
available today and help researchers and clinicians make an informed choice about which
strategy to use for experiments involving critically ill patients.
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Introduction
A multitude of isolation methods for extracellular vesi-
cles (EVs) has been developed and commercialized in
the last decade. Many methods claim rapid, reliable
and highly efficient isolation from serum, yet there is
no consensus on each method’s suitability for scientific
and clinical applications. Comparative data on meth-
ods for isolating EVs from patient biofluids are scarce,
despite clear interest in utilizing EVs and their miRNA
cargo for biomarker studies. Further, few attempts have
been made to comprehensively analyse vesicular
miRNAs in biofluid samples from critically ill patients,
a population highly relevant to many clinical situations.
This work compares five different methods of EV iso-
lation and their suitability for miRNA-based biomarker
discovery. We isolated serum EVs from sepsis patients
and healthy volunteers, sequenced their small RNA
cargo and performed differential miRNA expression
analysis. Additional experiments assessed method-spe-
cific differences in vesicle composition and morphol-
ogy. Our data reveal that precipitation and membrane
affinity are highly suitable for both small RNA-Seq and
patient classification based on cell-free miRNAs.
Comparative evaluation demonstrates that miRNA
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yield correlates with robust separation of sepsis patients
and healthy individuals, while vesicle purity seems less
relevant for RNA-based biomarker applications.
Differences in size, quantity and composition of iso-
lated vesicles indicate that each method captures dis-
tinctive, but partially overlapping EV populations
accompanied by varying degrees of contamination
with non-EV material.
EVs are intercellular communicators with key func-
tions in physiological and pathological processes and
have recently garnered significant interest as potential
diagnostic and therapeutic agents. Rapidly increasing
research in this field is accompanied by the demand for
reproducible, time-efficient and economic isolation
methods. A recent survey conducted by Gardiner
et al. revealed that although ultracentrifugation (UC)
remains the most commonly used isolation method,
other approaches have gained preference when starting
volume is limited [1]. Capturing EVs from blood-based
biofluids such as serum and plasma is of particular
interest for clinical applications. As a consequence,
manufacturers offer a wide array of commercial isola-
tion kits. These rely on principles ranging from filtra-
tion, precipitation and sedimentation to size-exclusion
chromatography (SEC) and immunocapture.
One of the most important aspects of EV research is
analysing their nucleic acid cargo, particularly small
RNAs. These are commonly quantified by RT-qPCR
or, increasingly, comprehensive transcriptomic profil-
ing by next-generation sequencing (NGS, small RNA-
Seq). Applications of EV transcriptomics range from
basic research to biomarker discovery and drug devel-
opment, making use of EVs as an easily accessible,
enriched sampling fraction [2,3]. Inferring credible
information from the transcriptome relies on precise
quantification of target RNA, which in turn requires
samples of high quality and integrity [4]. Additionally,
methods for RNA extraction itself influence down-
stream analyses by yielding non-identical, kit-specific
isolates [5]. This holds true particularly for extracellu-
lar RNA, which bears additional challenges such as low
concentrations, diminished RNA integrity and high
variability between individuals. Indeed, recent publica-
tions have highlighted the impact of cell-free RNA
extraction strategies on small RNA-Seq, reporting
quantitative and qualitative differences in resulting
sequencing libraries [6,7].
Similarly, the impact of EV isolation strategies on
RNA quantification assays has been demonstrated for
cell culture supernatant [8], urine [9,10], milk [11] and
serum [12]. Depending on the respective isolation
principle, different populations of EVs with varying
degrees of contamination seem to be isolated, resulting
in only partially overlapping RNA profiles. Being able
to detect specific RNA patterns in bulk populations of
blood-derived EVs is challenging due to the vesicular
secretome’s complexity. Although most EVs in blood
are secreted by erythrocytes, platelets and endothelial
cells, various other tissues also secrete vesicles into the
circulation, further complicating analysis [13,14].
Multiple classes of EVs are secreted from even one
specific cell type, each carrying its individual RNA
signature [15]. Beyond RNA profiles, kit-specific iso-
lates also differ in EV composition, size, concentration,
purity and functionality [16–20]. Selecting appropriate
isolation methods is therefore a critical step in all areas
of EV research.
There are excellent publications comparing differ-
ent strategies of isolating EVs from human serum for
RNA analyses. Rekker et al., Andreu et al. and
Crossland et al. relied on RT-qPCR to profile vesicu-
lar miRNAs, comparing isolation based on UC, pre-
cipitation and filtration [12,21,22]. Helwa et al.
isolated EVs from different starting volumes by pre-
cipitation and UC and quantified associated miRNAs
by droplet digital PCR [23]. Analysing EV miRNAs
using PCR-based assays is an important and well-
established approach supported by excellent protocols
and methods [24–26].
However, as NGS has become an increasingly pop-
ular downstream application to study miRNAs in EVs,
it is crucial to define the EV isolation method most
suitable for this particular technique. Several previous
publications reported the feasibility and utility of
sequencing small RNA in EVs isolated from serum,
plasma, urine, and cell culture supernatant [2,27–30].
Small RNA-Seq experiments often focus on valuable
applications such as liquid biopsy-based diagnostics
and, consequently, clinical samples. Screening potential
isolation methods should therefore include samples
from healthy individuals as well as diseased patients,
who often display severe anomalies in blood para-
meters. These matrix effects could conceivably interfere
with EV isolation and hamper the transfer of meth-
odologies from healthy to diseased subjects. Prime
examples of critically ill patients are individuals suffer-
ing from sepsis and septic shock. This complex, life-
threatening disease comes along with various clinical
complications such as multiple organ failure, dysregu-
lated coagulation and altered blood lipid profiles
[31,32]. Findings derived from comparing EV isolation
strategies for healthy donors, however, might not be
readily transferred to such challenging samples. We
therefore believe it is important to verify each method’s
applicability in samples relevant for the respective clin-
ical situation.
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The objective of the current study was to compare
several methods of isolating EVs from healthy and
septic sera and to identify the one most suitable for
biomarker-focused small RNA-Seq in this population
of critically ill patients. Routine biomarker applications
call for time-efficient, simple and streamlined proce-
dures, ideally provided to clinical laboratories as one-
box solutions. We did therefore not screen all potential
combinations of EV isolation and RNA extraction
methods but focused on either recommended RNA
kits by the same manufacturer or combinations com-
monly used in the EV field. Additionally, isolates from
each method were comparatively characterized in order
to assess method-specific differences in captured EV
populations and potential contaminating material.
Material and methods
Ethics approval and consent to participate
The study was approved by the Ethics Committee of the
Medical Faculty of the University of Munich (protocol
#551-14). Written informed consent and approval of a
patient’s legal representative was obtained when the
patient lacked capacity to give informed consent for par-
ticipation in the study. The study was carried out in
accordance with approved guidelines, and all study sam-
ples were anonymized during analysis. Written informed
consent for publication of blinded individual person’s
data was obtained from each participant or the patient’s
legal representative.
Patient recruitment
Four patients with sepsis and five patients in septic shock
were included in the study and sex-matched to 10 healthy
volunteers (Supplemental Table 1). Patients included in
the study were >18 years of age and within 24 h of admis-
sion to the intensive care unit (ICU). Exclusion criteria
were pregnancy, immunosuppression, leukopenia, haema-
tological malignancies or the initiation of palliative care.
Healthy volunteers were recruited from hospital personnel
and by advertisement. Only volunteers with a Charlson
Comorbidity Index [33] of ≤1 were included.
Sample collection
Blood was drawn from 20G catheters within the radial
artery of sepsis patients on the day of admission to the
ICU (day 0) and 24 h later (day 1). Healthy volunteers
were sampled by venipuncture using 20G needles. In
order to prevent haemolysis, aspiration was performed
slowly and evenly for both procedures. Blood was col-
lected in 9 ml serum tubes (S-Monovette, Sarstedt
AG&Co) and centrifuged at 3400 g for 10 min at
room temperature (RT) within 10 min of sampling.
Resulting serum was aliquoted and stored at −80 °C.
Isolation of extracellular vesicles
EVs were isolated from serum using four commercially
available isolation kits as well as differential UC
(Table 1). One millilitre serum from each patient and
volunteer was used as starting material for all isolation
methods. EV isolation was performed as detailed
below, following manufacturer’s recommendations for
pre-clearing of serum and subsequent steps. For all
commercial isolation methods, we sequenced vesicular
RNA from both patients and volunteers. Small RNA-
Seq was performed for all samples except in the case of
UC-derived EVs where it was only performed for
healthy volunteers, but not for sepsis patients, as
serum availability was limited. Serum EVs from day 0
were used for RNA extraction and small RNA-Seq.
Five septic shock patients and five matched volun-
teers from our small RNA-Seq cohort were selected for
additional biological characterization of EVs. In these
supplemental experiments, we isolated EVs from 1 ml
serum sampled on day 1 of intensive care therapy in
patients with sepsis. These day 1 EVs were isolated as
described below, concentrated to 50 µl using Amicon
Ultra-4 30 kDa NMWL spin filters (Merck Millipore)
and split into separate aliquots for protein analysis and
particle characterization, respectively. A schematic dia-
gram that summarizes all steps of the EV isolation and
characterization workflow is provided in Figure 1.
Precipitation
EVs were precipitated from 1 ml serum using the
miRCURY Exosome Isolation Kit (Exiqon) according to
Table 1. EV isolation methods and RNA extraction kits utilized in this study.
Principle of EV isolation Method RNA extraction kit
Precipitation miRCURY Exosome Isolation Kit (Exiqon) miRCURY RNA Isolation Kit – Biofluids (Exiqon)
Size-exclusion chromatography Exo-spin Midi Columns (Cell Guidance Systems) miRCURY RNA Isolation Kit – Biofluids (Exiqon)
Size-exclusion chromatography qEV Columns (Izon Science) miRCURY RNA Isolation Kit – Biofluids (Exiqon)
Membrane affinity exoRNeasy Serum-Plasma Midi Kit (Qiagen) exoRNeasy Serum/Plasma Midi Kit (Qiagen)
Sedimentation Differential ultracentrifugation
(Beckman Coulter Optima LE-80K)
exoRNeasy Serum/Plasma Midi Kit (Qiagen)
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the manufacturer’s instructions. For RNA extraction, EV
pellets were lysed with the provided miRCURY biofluid
lysis solution. Pellets for biological characterization were
resuspended in phosphate-buffered saline (PBS).
Size-exclusion chromatography
For Exo-spin (Cell Guidance Systems), EVs from 1 ml
serum were purified on the provided columns and
eluted in 3 ml particle-free PBS according to the man-
ufacturer’s quick start protocol. For qEV (Izon
Science), columns were equilibrated, overlaid with 1
ml serum and flushed with particle-free PBS, collecting
sequential fractions of 0.5 ml. Fractions 7–9 were
pooled to maximize EV yield.
Membrane affinity
Pre-cleared serum was applied to exoEasy columns
(Qiagen) as per the manufacturer’s protocol. EVs
were captured and washed using reagents provided in
the kit. For RNA extraction, EVs bound to the mem-
brane were lysed by adding QIAzol (Qiagen). Intact
EVs for biological characterization were eluted from
the column by addition of the provided buffer XE
(analogous to the procedures in Qiagen’s exoEasy kit).
Sedimentation
Serum was diluted 1:4 in PBS and subjected to low-
speed centrifugation (12,000 g, 1 h, k-factor: 1401.3).
EVs from the pre-cleared supernatant were then pel-
leted at 120,000 g for 14 h (k-factor: 139.7). All cen-
trifugation steps were carried out at 4°C using an
Optima LE-80K ultracentrifuge (Beckman Coulter)
and a SW60 rotor. Pellets were lysed in QIAzol for
RNA extraction or resuspended in PBS for EV
characterization.
RNA extraction and characterization
Total RNA was extracted from day 0 serum EVs using
commercial column-based kits listed in Table 1. For all
extraction methods, RNA eluates were reapplied to the
membrane for a second elution.
Precipitation
RNA was extracted from EV lysates using the corre-
sponding miRCURY RNA Isolation Kit for biofluids.
Procedures were carried out according to the manufac-
turer’s protocol, and RNA was eluted in 30 µl nuclease-
free water.
Size-exclusion chromatography
Eluted EVs (Exo-spin: 3 ml; qEV: 1.5 ml) were con-
centrated to 200 µl on Amicon Ultra-4 30 kDa NMWL
spin filters. RNA was subsequently extracted from the
concentrate using the miRCURY biofluids kit as
described above.
Figure 1. Schematic summary of EV isolation, RNA extraction and downstream analyses. EVs were isolated from human serum using
five (healthy donors) or four (sepsis patients) different methods. After extracting total RNA from EV isolates, small RNA species were
profiled by NGS. Differential expression of miRNAs between volunteers and patients was assessed to identify potential biomarker
candidates. Sera from a subset of volunteers and patients were used to additionally characterize isolates from each method by
Western blot (WB), nanoparticle tracking analysis (NTA) and transmission electron microscopy (TEM).
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Membrane affinity
RNA was extracted from EVs lysed in QIAzol using
reagents provided in the exoRNeasy kit. Procedures
were carried out according to the manufacturer’s pro-
tocol, and RNA was eluted in 14 µl nuclease-free water.
Differential UC
Following lysis of pellets in QIAzol, RNA was extracted
using the exoRNeasy kit as described above.
In order to compensate for the varying elution
volumes, all RNAs were gently dried in a centrifugal
evaporator and resuspended in 10 µl nuclease-free
water. Yield and size distribution of EV-RNA were
assessed by capillary electrophoresis on the 2100
Bioanalyzer (Agilent Technologies). We used the
RNA 6000 Pico Assay (Agilent Technologies) to assess
the total RNA profile including potential contamina-
tions with cellular RNA.
Next-Generation Sequencing
EV-RNA from sepsis patients and healthy volunteers
was profiled by small RNA-Seq. For all isolation meth-
ods, we used 60% (6 µl) of eluted total RNA as starting
material. Library preparation was performed as
described in Reithmair et al. [34], using the NEBNext
Multiplex Small RNA Library Prep Set for Illumina
(New England BioLabs Inc.). To compensate for the
low RNA input, all adaptors and primers were diluted
1:2 in nuclease-free water. Size selection of PCR pro-
ducts was performed by high-resolution 4% agarose gel
electrophoresis, selecting bands of 130–150 base pairs.
Fragment sizes of purified libraries were assessed using
capillary electrophoresis prior to 50 cycles of single-end
sequencing on the HiSeq2500 (Illumina Inc.).
Data analysis
Sequencing data were processed as described elsewhere
[35]. Briefly, FastQC (version 0.10.1) [36] was used to
assess sequence length distribution and quality. Adaptor
sequences were trimmed using Btrim [37], and all reads
without adaptors were discarded. Additionally, reads
shorter than 16 nt, probably degradation products from
longer coding and non-coding RNA species, were
excluded from the data set before proceeding to align-
ment [4]. To avoid false-positive hits during miRNA
analysis, reads that mapped to sequences from human
rRNA, tRNA, snRNA and snoRNA (obtained from
RNAcentral) were initially removed from the data set
[38]. Remaining reads were then aligned to human
miRNA sequences in the most recent version (21) of
miRBase [39]. Mapping was performed using Bowtie
[40] and the “best” alignment algorithm, allowing one
mismatch for alignment to both RNAcentral and
miRBase. For all RNA classes, final read count tables
were generated directly from Bowtie output by summing
up all hits per sequence. Differential gene expression
(DGE) analysis was subsequently performed via the
Bioconductor Package DESeq2 (version 1.8.1) [41]
using the included normalization strategy based on med-
ian ratios of mean miRNA expression and the
Benjamini–Hochberg method to correct for false discov-
ery. A log2 fold change ≥|1| and an adjusted p-value of
≤0.05 were set as thresholds to identify significantly regu-
lated miRNAs. Only transcripts with a baseMean ≥50
were included in the analysis. Hierarchical clustering
(Euclidean distances, Ward’s method), principal compo-
nent analysis (regularized log-transformed, sizefactor-
corrected counts obtained from DESeq2) and visualiza-
tion of significantly regulated miRNAs in Venn diagrams
were carried out in R (version 3.4.0) using the packages
gplots, ggplots2, RColorBrewer, dendextend, ggfortify
and VennDiagram [42–48]. Trimmed sequence reads
were deposited in the European Nucleotide Archive
under accession number PRJEB24913 (http://www.ebi.
ac.uk/ena/data/view/PRJEB24913).
Nanoparticle tracking analysis
EV suspensions were diluted in particle-free PBS (pre-
pared by a 120,000 g spin at 4°C for 14 h, k-factor: 231.6)
and analysed using a NanoSight LM10 (Malvern
Instruments GmbH) equipped with a 405-nm laser and
a high-sensitivity sCMOS camera. Samples were intro-
ducedmanually, and six videos of 45 s each were captured
at a frame rate of 25 frames/second. With sample tem-
peratures monitored manually, individual particles were
tracked using NTA 3.0 software (Malvern Instruments
GmbH) at camera level 10 and the Finite Track Length
Adjustment (FTLA) algorithm. For analysis, we used a
conservative detection threshold with blur and minimum
track length set to auto and only considered captures with
at least 2000 completed tracks. Starting from concentra-
tions measured by NTA, initial particle concentrations in
serum were calculated using the respective dilution fac-
tors for each sample as described elsewhere [49].
Transmission electron microscopy
EVs were adsorbed onto formvar/carbon-coated 200-
mesh nickel grids (Electron Microscopy Sciences) for 20
min at RT. Next, grids were fixed with 2% paraformalde-
hyde for 20 min, washed with PBS three times and fixed
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with 1% glutaraldehyde for 5min. After six washing steps
with distilled water, grids were negative stained with 4 %
uranyl acetate for 5 min. Finally, grids were embedded in
0.4 % uranyl acetate / 0.2 %methyl cellulose for 10min on
ice in the dark and air-dried overnight. Images were
acquired on a Zeiss EM900 (Carl Zeiss Microscopy
GmbH) with a wide-angle dual-speed 2K-CCD camera
at 80 kV.
Western blot
EV samples were lysed in ice-cold
Radioimmunoprecipitation Assay (RIPA) buffer on
ice for 15 min intermitted by three bouts of sonication
in a water bath. After centrifugation at 13,000 g for
10 min, protein concentration in the supernatant was
analysed using Bicinchoninic Acid (BCA) assay (Sigma
Aldrich). Input for exoRNeasy, Exo-spin, miRCURY
and UC was normalized to 25 µg total protein. Due
to very low protein concentrations, maximum volumes
were loaded on the gel for qEV. For electrophoresis,
samples were reduced in Laemmli buffer and heated at
70 °C for 10 min. Protein lysates for analysis of CD63
were incubated with non-reducing sample buffer at RT
for 20 min. Proteins were separated using NuPAGE 4–
12% Bis-Tris Gels (Invitrogen) prior to transfer to a
0.45 µm nitrocellulose membrane (GE Healthcare Life
Sciences). Membranes were blocked with 1% non-fat
milk powder in Phosphate Buffered Saline with Tween
(PBST) for 1 h at RT and incubated with primary
antibodies at 4°C overnight. Secondary antibodies
were added for 1 h at RT. After washing with blocking
buffer, blots were developed using the Clarity Western
ECL Blotting Substrate Kit (Bio-Rad). Primary antibo-
dies were from Abcam (mouse anti-TSG101 clone
4A10, ab83, 1:800, rabbit anti-Syntenin clone
EPR8102, 1:5000, ab57113, 1:250, mouse anti-CD63,
clone TS63, ab59479, 1:500, mouse anti-Human
Serum Albumin clone 1A9, ab37989, 1:250), OriGene
(rabbit anti-CD81, TA343598, 1:500) and Biomol (goat
anti-Calnexin, WA-AF1179a, 1:2500). All marker pro-
teins except CD63 were analysed using reducing con-
ditions. HRP-conjugated secondary antibodies were
purchased from Abcam (goat anti-Mouse, ab97040,
1:10,000, goat anti-Rabbit, ab97080, 1:10,000, rabbit
anti-Goat, ab97105, 1:10,000).
Results
Analysis of isolation-specific EV-RNA composition
by small RNA-Seq
Total EV-RNA was characterized by capillary electro-
phoresis, revealing major differences in quantity and
size distribution across EV isolation strategies
(Supplemental Figure 1). Similarly, sequencing of
small RNA resulted in vastly differing total library
sizes, ranging from 3.68E6 ± 1.72E6 reads (qEV sepsis)
to 1.17E7 ± 3.76E6 reads (UC volunteer). Two EV
samples precipitated from sepsis patients did not prop-
erly amplify during sequencing and were excluded
from subsequent analyses. Method-dependent capture
of miRNAs was assessed by aligning reads to miRBase
and expressing mapped miRNAs as percentages of
library size (Figure 2). miRNA enrichment was highest
for precipitation-based EV isolation, followed by UC,
membrane affinity and SEC. Even though library sizes
were similar for UC, exoRNeasy and miRCURY, the
latter displayed a 3.5–5-fold higher percentage of
mapped miRNAs, respectively. For all isolation meth-
ods, relative frequencies of mapped miRNAs for sepsis
patients were slightly lower than for volunteers
(Figure 2). The top 10 most highly expressed miRNAs
for each method are provided in Supplemental Table 2.
Figure 2. Mean library size and mapped miRNAs for EVs isolated from healthy volunteers (a) and sepsis patients (b). miRNA
mapping frequencies (red diamonds) are expressed as percentages of total library size and plotted against the right x-axes.
Enrichment of miRNA reads was highest for miRCURY (35.08% and 27.56% for volunteers and patients, respectively) and lowest for
qEV (0.79% for volunteers and 0.57% for patients). All data are mean ± SD for 10 volunteers and 9 sepsis patients.
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Similar differences were found when mapping reads
to further classes of small non-coding RNA (Figure 3).
Expressed as the ratio of non-target reads to miRNA
reads, both SEC-based methods tended to isolate more
rRNA fragments than other methods (Supplemental
Figure 2). Increased frequencies of rRNA reads were
also observed in sepsis EVs isolated by membrane
affinity. Additionally, membrane affinity captured sig-
nificantly more tRNA fragments than other methods
from both septic and healthy EVs. SEC-based methods,
particularly qEV, also isolated large numbers of frag-
ments shorter than 15 nt. Mean library sizes, mapped
miRNAs and results from DGE are provided in
Supplemental Table 3.
EV-miRNAs from precipitation and membrane
affinity separate volunteers and patients
DESeq2 was used to assess differential regulation of
miRNA levels between sepsis patients and volunteers
for commercial isolation kits. After applying stringent
filtering criteria (baseMean ≥50, log2 fold change ≥|1|,
adjusted p-value ≤0.05), we found 6 (qEV), 14 (Exo-
spin), 60 (exoRNeasy) and 90 (miRCURY) miRNAs to
be significantly regulated. While there was minimal
overlap between all EV isolation strategies, most
regulated miRNAs were unique for a specific isolation
method (Figure 4). A common set of two significantly
regulated miRNAs was detected for all EV isolation
methods. Data for unfiltered differential expression
analysis are provided in Supplemental Figure 3.
Similarities between miRNA patterns from each
patient and isolation method were assessed by hier-
archical clustering analysis (HCA) (Figure 5). Based
on all miRNA reads, HCA separated isolation by pre-
cipitation, UC and membrane affinity from both SEC-
based methods. Within these principal clusters, preci-
pitation and membrane affinity flawlessly separated
sepsis patients from healthy volunteers. Even though
samples from precipitation and UC showed a high
degree of similarity, UC volunteers were more closely
related to miRCURY sepsis patients. Clustering of
miRNAs from SEC isolation revealed substantial het-
erogeneity within and overlap between qEV and Exo-
spin. Subsequently, these methods did not accurately
distinguish volunteers from patients. This was also
demonstrated by principal component analysis
(Supplemental Figure 4), where separation of patient
groups was achieved exclusively by miRCURY and
exoRNeasy.
The number of differentially regulated miRNAs
detected in DESeq2 analysis varied significantly
Figure 3. Mapping statistics for various classes of small non-coding RNA. Highest frequencies of miRNA mapping were observed in
isolates from precipitation, sedimentation and membrane affinity. Both SEC-based methods were prone to capture short sequences,
while libraries from membrane affinity-derived samples contained an increased share of tRNA fragments. Short: sequence is shorter
than 15 nt; unmapped: sequence did not align to human rRNA, snRNA, snoRNA, tRNA or miRNA. Data are expressed as mean
mapping percentages for 10 volunteers (V) and 9 sepsis patients (S).
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between isolation methods (Figure 4). Differentially
expressed miRNAs as well as corresponding log2 fold
changes and adjusted p-values for each method are
provided in Supplemental Table 4. As predicted by
sequencing output, methods yielding larger libraries
also tended to result in more dysregulated miRNAs
and greater fold changes. A common set of two
miRNAs was found to be differentially expressed in
EVs isolated by all methods. In EVs from sepsis
patients, miR-122-5p was upregulated with log2 fold
changes of 1.86 (Exo-spin) to 4.53 (exoRNeasy). miR-
151a-3p, on the other hand, was downregulated in
septic EVs, displaying log2 fold changes of −1.18
(miRCURY) to −1.65 (exoRNeasy) (Table 2).
EV populations isolated by divergent methods
differ in size, concentration and purity
EVs captured by all isolation methods were analysed by
NTA. Mean and mode particle diameters ranged from
104.46 ± 11.96 nm and 80.02 ± 10.12 nm (miRCURY
volunteer) to 202.86 ± 10.70 nm and 174.48 ± 18.20 nm
(exoRNeasy volunteer), respectively (Figure 6(a)). Size dis-
tributions for sepsis patients were slightly broader for all
Figure 4. Differential expression of miRNAs in EVs isolated by commercial methods. Precipitation and membrane affinity yielded
high numbers of differentially regulated miRNAs (miRCURY: 90; exoRNeasy: 60). Far fewer regulated miRNAs were detected in SEC-
derived samples (Exo-spin: 14; qEV: 6). Two differentially regulated miRNAs were detected in EVs isolated by all methods. Data are
filtered for baseMean ≥50, log2 fold change ≥|1| and adjusted p-value ≤0.05.
Figure 5. Hierarchical clustering analysis of miRNAs in EVs isolated by commercial methods. Samples split up into two clusters,
separating precipitation and membrane affinity from both SEC-based methods. miRCURY (blue) and exoRNeasy (red) accurately
distinguished between healthy volunteers (darker shades, V) and sepsis patients (lighter shades, S). miRNAs isolated from SEC-EVs
(Exo-spin, qEV) showed noticeable heterogeneity and were less capable of separating volunteers and patients.
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isolation methods except qEV, but no significant differ-
ences in particle diameter were detected between volun-
teers and patients. The total number of particles isolated
from 1 ml serum was highest for miRCURY, followed by
Exo-spin, qEV, UC and exoRNeasy (Figure 6(b)).
Additional plots for particle diameter and concentration
are provided in Supplemental Figure 5.
Estimates for sample purity were calculated as ratios
between NTA particle counts and protein concentra-
tions [50]. While calculating these ratios does not
necessarily help characterize a sample’s EV fraction
and their homogeneity, it provides a useful metric for
assessing to which degree a sample is contaminated
with non-EV protein. SEC-based isolation yielded iso-
lates with significantly higher particle to protein ratios
than all other methods, indicating less co-isolation of
soluble protein (Figure 6(b)). Isolates derived from
precipitation and UC, on the other hand, displayed
the lowest ratios due to increased protein contamina-
tion. Additional data on particle size, concentration
and purity are included in Supplemental Table 5.
Next, we assessed particle morphology by TEM.
Confirming our findings from NTA, we detected par-
ticles with EV morphology and size for all isolation
methods (Figure 7). While the majority of vesicles were
less than 200 nm in diameter for all methods, precipi-
tation-derived EVs seem to be additionally enriched for
particles smaller than 100 nm.
Enrichment of contaminating soluble protein in EVs
isolated by precipitation and UC
Prior to immunoblotting, total protein in EV lysates from
each method was quantified by BCA assay. Similar to
Table 2. Common set of miRNAs differentially regulated between sepsis and healthy controls for all
EV isolation methods.
miR-122-5p
Isolation method log2FC p-adj
exoRNeasy 4.53 6.72E-17
qEV 2.11 2.73E-04
Exo-spin 1.86 2.72E-04
miRCURY 2.88 1.42E-07
miR-151a-3p
Isolation method log2FC p-adj
exoRNeasy −1.65 4.61E-10
qEV −1.55 4.97E-06
Exo-spin −1.19 3.92E-02
miRCURY −1.18 5.72E-03
Log2FC: log2 fold change; p-adj: DESeq2-adjusted p-value.
Figure 6. Analysis of EVs by NTA demonstrates differences in size distribution (a). Whiskers indicate 1st and 99th percentiles; line:
mean diameter; dot: modal diameter; V: volunteer; S: sepsis patient. Precipitation- and membrane affinity-based methods isolated
the smallest and largest EVs, respectively. Concentration and purity of isolated EVs differed depending on isolation strategies (b).
Black bars indicate the absolute number of vesicles isolated from 1 ml serum; red diamonds plotted against the right x-axis
represent vesicle purity defined as the particle to protein ratio. While precipitation most efficiently isolated EVs from serum, SEC-
based isolation yielded fewer but highly pure vesicles. Asterisks indicate significant differences in particle numbers compared to
miRCURY. *p < 0.05; **p < 0.01; NS: not significant. All data are mean ± SD for five volunteers and five sepsis patients.
JOURNAL OF EXTRACELLULAR VESICLES 9
initial RNA concentrations and sequencing library sizes,
striking differences in protein yield were observed
(Supplemental Table 6). The amount of total protein in
EV isolates ranged from 11.73 ± 5.18 µg (qEV, volunteer)
to 26,202.95 ± 3904.31 µg (precipitation, volunteer). On
average, precipitation and UC captured 50–80 times the
amount of protein derived from SEC and membrane
affinity isolations. Protein recovery from volunteer sam-
ples was significantly higher (p < 0.05) for exoRNeasy,
miRCURY and UC, but failed to reach significance for
Exo-spin (p = 0.87). Isolation by qEV captured signifi-
cantly more (p = 0.01) protein from sepsis patients.
EV-specific proteins as well as negative markers
were assessed by Western blot (Figure 8). CD63, a
commonly used vesicle marker, was detected as a
broad smear between 30 and 60 kDa, indicating differ-
entially glycosylated forms of the protein. EVs isolated
by membrane affinity showed high signal intensities for
CD63, while both SEC-based methods resulted in
weaker bands. No CD63 was detected for isolation by
precipitation and UC. A similar pattern was observed
for syntenin, showing clear signals for exoRNeasy, qEV
and Exo-spin, but not for miRCURY and UC. EV
markers CD81 and TSG101 were not detected for any
isolation strategy.
Nonspecific staining of total EV protein by Ponceau
S revealed a very prominent band at 60–70 kDa for
Exo-spin, miRCURY and UC (Supplemental Figure 6),
potentially indicating co-isolation of non-vesicular
material. Human serum albumin (HSA), the most
abundant blood protein, was selected as a likely candi-
date for protein contamination in EV preparations.
Indeed, Western blot analysis revealed extraordinarily
high HSA levels for miRCURY and UC, but also
exoRNeasy and Exo-spin (Figure 8). Only minor
amounts of HSA were detected for qEV isolations.
Figure 7. Morphology of serum EVs by transmission electron microscopy. Images are representative for three separate biological
replicates for both volunteers (top panel) and sepsis patients (bottom panel). Scale bars are 500 nm (top row) and 100 nm (bottom row).
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Protein lysates were also analysed for contamination
with cellular fragments as indicated by the endoplasmic
reticulum protein calnexin. In contrast to HSA, no
calnexin signal was detected for any of the isolation
methods. These findings hint at a contamination with
soluble proteins, but not with non-vesicular membrane
fragments. None of the detected protein markers
showed significant enrichment for either volunteers
or sepsis patients.
Increased contamination with soluble proteins such
as HSA leads to an underrepresentation of marker
proteins in EV lysates. As no EV markers were detected
for miRCURY and UC, we increased the input for
immunoblotting to 50 µg total protein. Additionally,
EVs isolated by these techniques were further purified
by iodixanol density gradient centrifugation to remove
soluble proteins. Even though increasing total protein
did not lead to the detection of protein markers
(Supplemental Figure 7), floatation into a density gra-
dient effectively separated contaminating HSA from
EVs captured by sedimentation and precipitation.
While the majority of HSA was retained in fractions
of 1.02–1.07 g/ml, EV markers syntenin and CD63
were identified in a fraction of 1.18 g/ml, correspond-
ing to previously reported floatation densities of blood-
derived EVs [51] (Figure 9).
Discussion
EVs fascinate researchers in basic science and translational
applications alike, but our understanding of EV biogenesis,
secretion, tissue retention and potential therapeutic use
depends on the ability to isolate and characterize specific,
well-defined populations of vesicles. The question as to
which EV isolation method to utilize for a given down-
stream application is a frequent subject of controversial
debate that has yet to be settled. In this study, we qualita-
tively and quantitatively compared EV isolation strategies
based on different physiochemical mechanisms ranging
from sedimentation and precipitation to membrane affi-
nity and SEC. Importantly, we used serum as a biofluid
relevant to clinical applications and included diseased
patients as well as healthy volunteers. As isolationmethods
need to be validated using clinical samples, we opted for
Figure 8. Analysis of marker proteins in EVs from volunteers (left) and sepsis patients (right). EV markers CD63 and syntenin were
detected in vesicles isolated by membrane affinity (exoRNeasy) and SEC (qEV, Exo-spin), but not precipitation (miRCURY) and UC. All
EV isolates were negative for TSG101, CD81 and calnexin. Significant albumin contamination of EVs was found for non-SEC isolation
methods. Results are representative for three separate biological replicates for both volunteers and sepsis patients.
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sepsis patients, who represent a prime example for both
interindividual variability and complex aberrations in
blood parameters.
High-throughput sequencing has evolved into a main-
stream method of analysing nucleic acids. It allows precise
quantification of miRNAs and sheds light on RNA com-
position, co-isolation of non-target molecules and novel
classes of non-coding RNA. Using Illumina small RNA-
Seq, we found that vesicular RNA profiles greatly depend
on the respective EV isolation strategy. While the methods
less specific for EVs (precipitation, sedimentation and
membrane affinity) resulted in higher absolute and relative
numbers of mapped miRNAs, a more stringent size selec-
tion on EVs (SEC) led to lower mapping rates and an
abundance of short RNA fragments in preparations
(Figure 3). Furthermore, isolates from different methods
were reproducibly enriched in fragments of additional
short non-coding RNA classes such as tRNA. We have
used two different RNA extraction kits in this study, and
varying combinations of EV isolation and RNA extraction
methods might yield slightly different results [5,52].
However, based on the vastly different characteristics of
the material captured by each method, we believe that EV
isolation itself has a far greater impact on downstream
RNA analysis than the respective extraction method
(Figure 6).
The prime objective of this study was to assess EV
isolation methods regarding their suitability for
Figure 9. Analysis of EV markers and human serum albumin in EVs isolated by precipitation and sedimentation and further purified
by iodixanol density gradient centrifugation. CD63 and syntenin were detected in a density fraction of 1.18 g/ml, while the majority
of albumin floated in fractions of 1.02–1.05 g/ml. Results are representative for two separate biological replicates for both
volunteers (top panel) and patients (bottom panel).
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miRNA-based biomarker studies. In our data, the abil-
ity to separate healthy individuals from diseased
patients strongly correlated with sequencing output
for a given method: EV isolation based on precipitation
and membrane affinity resulted in higher absolute
numbers of mapped miRNA reads, more candidates
in DGE analysis and enhanced separation of groups
in hierarchical clustering. In contrast, low-output
methods (SEC) were also able to identify a core set of
two miRNAs differentially regulated regardless of iso-
lation strategy but did not reliably assign individual
samples to the correct study population (Figure 5).
Interestingly, only SEC-based methods generated simi-
lar or greater numbers of reads from diseased samples,
while precipitation and membrane affinity seemed to
work more effectively for healthy individuals
(Supplemental Table 3). This correlated only partially
with particle data from NTA, which indicate that both
qEV and exoRNeasy recover more particles from sepsis
sera. Even though assessing sequencing library size as a
standalone metric is of limited use, results from differ-
ential expression analysis correlated with higher
sequencing output and more diverse libraries in our
data. Library composition might, however, differ
depending on sample preparation, as demonstrated by
Huang et al. [28]. As different library preparation kits
tend to preferentially capture specific RNA sequences,
NGS data in different experiments might be biased for
certain transcripts. Highly abundant miRNAs are less
affected by library preparation-induced biases, which
might be more problematic for low-abundance tran-
scripts or biomarker studies in diseases with less
extreme alterations in miRNA expression. In conclu-
sion, isolation methods less specific for EVs yielded
more RNA, better libraries and, therefore, increased
separation of patient groups. More specific methods,
which purify EVs rather than enrich cell-free material
in general, resulted in less complex libraries, fewer
miRNA reads and poor performance in clustering. It
is worth noting that increasing sequencing depth for
RNA associated with pure vesicle preparations might in
turn improve results from DGE analysis.
Observed variations in RNA composition could be
attributed to a number of factors including a method’s
efficiency of isolating EVs, isolation of non-overlapping
subpopulations of vesicles and co-isolation of non-vesicu-
lar RNA. As blood samples from sepsis patients and
healthy donors were drawn using slightly different meth-
ods, potential sampling-related batch effects might con-
found genuine disease effects. Yet, as shown in hierarchical
clustering (Figure 5), poor separation of sample groups for
SEC-based isolation indicates the absence of a systematic
batch effect caused by blood sampling. Additionally, in a
separate study on paired samples collected by arterial and
venous catheters from the same donors, we couldn’t detect
any significant sampling-dependent differences in EV
morphology and associated miRNA profiles (manuscript
in preparation). Differential expression of miRNAs in this
study is therefore likely to be caused by sepsis itself, rather
than by collection methods.
Several of the miRNAs we found to be differentially
expressed (Supplemental Table 4) have previously been
associated with sepsis and inflammation. Reithmair et al.
and Wang et al. reported increased levels of circulating
miR-193b-5p in EVs from sepsis patients and a strong
association with disease mortality [34,53]. miR-30a-5p,
upregulated in samples from exoRNeasy, miRCURY and
Exo-spin, is induced by inflammatory stimuli and discri-
minates sepsis from non-infectious systemic inflamma-
tory response syndrome [54,55]. Several groups reported
that treatingmacrophages with lipopolysaccharides (LPS)
increased expression of miR-155-5p, which, in turn, dam-
pened the immune response, protected septic mice from
cardiac dysfunction and improved survival [56–58].
Additionally, circulating levels of miR-155 were shown
to correlate with disease severity and poor prognosis in a
cohort of 60 sepsis patients [59]. In mice and rats, miR-
150-5p, upregulated in samples captured by membrane
affinity, was increased by polymicrobial sepsis and LPS
treatment, respectively [60,61]. Vasilescu et al. reported
plasma levels of miR-150-5p to correlate with sepsis
aggressiveness in a cohort of 17 sepsis patients [62]. In
concordance with previous findings in critically ill
patients, we detected miR-122-5p as upregulated in sam-
ples derived from all isolation methods. This miRNA is
commonly considered to be liver specific, and increased
serum concentrations have been reported in cases of liver
injury and hepatotoxicity [63]. Increased serum levels of
miR-122-5p were also reported in sepsis patients, corre-
lating with liver damage, coagulation disorders and mor-
tality [53,64,65]. A more recent publication by Roderburg
et al., however, demonstrated thatmiR-122-5p expression
in critically ill patients was dysregulated by hepatic injury
alone, independent of an infectious state [66]. Exclusively
focusing on the septic shock patients in our cohort might
have tightened expression patterns of disease-related
miRNAs, but as our goal was to assess EV isolation
methods capable of also detecting the less severe stage,
we did not perform separate analyses on this subgroup. In
conclusion, our findings match previous reports about
altered profiles of circulating miRNAs in critically ill
patients and animal models of sepsis, and crude prepara-
tions of cell-free RNA allow for more robust detection of
disease-associated differential expression.
In an attempt to shed light on the nature of vesicles
isolated by each method, we characterized intact particles
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using NTA. Unsurprisingly, all methods used in this
study isolated particles in the size range of small EVs.
Mean particle diameters, however, differed significantly:
membrane affinity captured EVs with diameters close to
200 nm, while precipitation isolated vesicles with an exo-
some-like diameter of 100–120 nm. These differences
might be due to capturing different EV populations or
manipulation of originally identical EVs during isolation
by aggregation [67] or coating with serum proteins [68].
In line with our findings, Stranska et al. recently reported
larger particle diameters for EV samples isolated from
human plasma by membrane affinity compared to SEC
[69]. For most kits, variability of particle diameters was
greater in sepsis samples, indicating disease-specific
changes in circulating vesicles, or interferences caused
by matrix effects in serum from critically ill patients. It
is also conceivable that an increased proportion of
immune cell-derived EVs or bacterial outer membrane
vesicles, typically ranging from 20 to 300 nm in diameter,
might contribute to the broader range of particles recov-
ered from septic sera [70,71].
Quantitative analysis of particles revealed another layer
of complexity, as precipitation captured both the smallest
and the highest number of EVs, whereas particles isolated
bymembrane affinity were larger andmuch less abundant.
For a given isolation method, seemingly high standard
deviations of particle sizes can most likely be attributed to
endogenous variability within patient groups. Recent work
by Eitan et al. revealed individual-specific set points for EV
concentration and composition, indicating the need for
larger cohorts in descriptive and clinical EV studies [49].
The slightly decreased concentration of EVs recovered
from sepsis patients by most methods could be due to less
efficient capture from patient sera, or genuinely lower EV
concentrations in serum caused by decreased secretion,
increased clearance from the bloodstream, dilution of
EVs by therapeutic blood products administered in the
ICUor a combination thereof. It should be noted, however,
that lipoproteins such as low-density lipoprotein (LDL)
outnumber EVs in cell-free blood by at least one order of
magnitude and are known to co-purify with EVs [72]. As
LDL and other common contaminants such as protein
aggregates mimic characteristics of genuine EVs, particle
quantification using NTA might overestimate EV concen-
trations in low-purity preparations and skew isolation-
dependent size profiles [73–75]. Interestingly, the ability
of extracellular RNA to separate healthy and diseased indi-
viduals did not seem to be tied to the diameter of the
corresponding EVs since methods isolating both very
small (precipitation) and very large (membrane affinity)
EVs performed best in differential expression analysis. As
these methods are prone to contamination with soluble
material (Figure 8), we cannot rule out the possibility that
separation of patient groups is based on RNA not asso-
ciated with EVs, but co-isolated from the non-vesicular
serum compartment. SEC-based methods, on the other
hand, isolated EVs contaminated with large quantities of
short RNA fragments, rendering them less suitable for
robust classification of patient samples. This discovery
raises questions about the origin of these fragments and
whether they are encapsulated in EVs or co-isolated from
non-vesicular blood compartments. While part of the
population of short fragments might be derived from
RNA degradation and library preparation artefacts such
as adaptor dimers, non-human RNA sequences could also
contribute to this category. Certain bacteria secrete cell-free
RNA, some of it vesicle-associated, which might have been
captured from septic sera by the EV isolationmethods used
here [76,77]. Additionally, reads categorized as unmapped
(Figure 3) might be derived from bacterial RNA, even
though the frequency of unmapped reads was not signifi-
cantly increased in sepsis samples. As differential contam-
ination of libraries with non-human sequences would
impair normalization to library size or reads per million,
we strictly normalized expression values for confirmed
human miRNAs. Analysing particle morphology by TEM
demonstrated that all methods isolated vesicles in the
100–200 nm size range. Isolates from precipitation did
not display significantly more vesicles than other methods,
indicating that non-vesicular particles such as protein
aggregates might have contributed to increased particle
counts in NTA [78]. The number of particles per field
shown in Figure 7 does not necessarily correlate to particle
concentrations from NTA since different dilution factors
were used for samples from each isolationmethod in TEM
imaging. In accordance with recent reports [79], we also
observed double vesicles and vesicles containing two or
more smaller vesicles.
Further profiling of EV isolates demonstrated an enrich-
ment in CD63 and syntenin for SEC-based andmembrane
affinity-based isolations, but not for precipitation and UC.
Potentially owing to insufficient starting material or tech-
nical factors, and in contrast to preexisting publications
[23,34,80], we did not detect TSG101 and CD81 for any
isolation method. Similar findings were recently presented
in a publication by Stranska et al., which demonstrated the
absence of CD81 and TSG101 in plasma EVs isolated by
membrane affinity [69]. Additionally, recent advances in
the field have demonstrated that so-called exosome mar-
kers can also be present on other classes of EVs and that EV
isolates are a heterogeneous mixture of various subpopula-
tions with specific protein profiles [81,82]. It is therefore
conceivable that isolationmethods are biased towards only
partially overlapping EV populations, resulting in different
protein profiles. Additionally, modifications of EVs during
isolation, including coating with precipitation polymers or
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serumproteins,mightmask antigens and impede detection
of marker proteins as observed elsewhere [83,84]. Even
though increasing the input for protein analysis helped
other investigators to detect markers in crude EV samples
[23], it was not sufficient for samples from precipitation
and sedimentation in our study. Additional purification by
density gradient centrifugation, however, established the
presence of EV markers syntenin and CD63 in fractions
with a density of 1.18 g/ml (Figure 9). While serum albu-
min and other soluble proteins overpowered EV markers
in crude isolates, floatation into a density gradient could be
used to specifically purify vesicles from pre-enriched sam-
ples. The endoplasmic reticulum marker calnexin could
not be detected in lysates from any of the isolation princi-
ples, indicating the absence of contaminating cellular frag-
ments and vesicles not originating from endosomes [85].
Contamination of EV preparations with highly abundant
blood proteins is a well-known problem, particularly for
proteomic analyses [86]. In line with earlier publications,
we demonstrate that precipitation- and sedimentation-
based isolations co-fractionate significant amounts of
serum albumin that mask genuine EV-enriched proteins.
Additionally, we herein confirm previous findings
[69,83,87] that SEC-based methods represent an efficient
way of removing high-abundance serum proteins
(Supplemental Figure 6), trading decreased vesicle yield
for higher purity [88].
Highly pure and well-defined populations of EVs,
however, might not be prerequisite for all research ques-
tions. While mechanistic and descriptive scrutinies are
crucial for basic research and developing EV therapeutics,
biomarker applications rely heavily on pronounced and
reproducible changes in the molecules of interest. A
recent publication by Quek et al. suggests that impurities
in vesicle preparations have little effect on downstream
nucleic acid quantification and states the utility of time-
efficient, but rather crude EV isolation methods for bio-
marker discovery [89]. In line with this, we report pre-
cipitation-based isolation to yield samples with lower
purity and significant protein contamination, but excel-
lent potential for transcriptomics-driven biomarker dis-
covery. We agree with previous publications stating that
enriching serum EVs by precipitation might be a viable
strategy for biomarker discovery studies [21,23]. Alvarez
et al. presented similar findings for profiling RNA bio-
markers in urinary EVs [9]. Decreased purity does not
have to be a limitation if the objective is enriching cell-
free miRNAs rather than purifying specific EV popula-
tions. If researchers strive to identify extracellular miRNA
signatures that separate patient populations, these could
be analysed regardless of their carriers [90]. As long as
samples isolated by a given method reproducibly provide
strong divisional capabilities for patient populations of
interest, comprehensively characterizing isolated vesicles
might not be a mandatory requirement for clinical bio-
marker applications. Given that precipitation is time effi-
cient, inexpensive and demands no specialized
equipment, it also seems to conveniently lend itself to
integration into clinical usage. However, in a research
field as vibrant and international, standardizing reagents
and protocols utilized for EV precipitation and character-
ization are crucial for generating valid and reproducible
data across laboratories [22,85,91].
In conclusion, we herein report that enriching cell-free
miRNAs by precipitation allows for reliable separation of
sepsis patients and healthy volunteers in sequencing-
based analyses. As extracellular RNA can be encapsulated
in vesicles or stabilized by binding to circulating proteins
such as argonaute 2 (Ago2), further investigations using
additional purification steps such as density gradient
centrifugation or SEC are needed to conclusively verify
if miRNAs dysregulated in this study are genuinely
encapsulated in EVs [92]. Based on our experiments, we
cannot rule out the possibility that miRNAs separating
patients and volunteers are associated with non-vesicular
carriers rather than EVs [93]. Should this be the case,
additional validation of sepsis-related miRNA signatures
might be carried out on total cell-free RNA without prior
enrichment of EVs, reducing time and cost of analysis.
Even though exosomes have been shown to provide an
enriched source of miRNA with higher predictive value
than total cell-free blood, miRNAs of diagnostic potential
might be associated with different carriers in a disease-
specific manner, calling for the careful validation of pre-
vious findings in each biomarker discovery process
[2,94]. In diseases with less drastic clinical manifestation
than sepsis, extracellular signalling could be more clearly
detectable in pure EVs as opposed to crude preparations
of cell-free RNA. Our findings might therefore not be
generalizable to all clinical applications, as a different
approach may be more appropriate for diseases other
than sepsis.
Even though the focus of this work was on transcrip-
tomic profiling of EVs, our findings could be transferred
to different routes of analysis as well. It has become
increasingly clear that the optimal method of EV isolation
differs depending on the respective research setting and
downstream analyses. Both failing to choose appropriate
isolation methods for a particular experiment and trying
to integrate results from multiple studies conducted with
inappropriate or incompatible methodology squander
resources decrease experimental validity and hamper
translation of research findings into practical applications.
This work therefore provides valuable guidance for navi-
gating the wide array of EV isolation methods available
today.
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